Creative Touch Permanent Makeup and Aesthetics

Headache occurs in approximately 22% of tirzepatide users with abdominal injection versus 11% with thigh injection—a 49% reduction through site selection. Unlike GI symptoms with obvious gut connection, headache variation by injection site suggests broader systemic differences in how medication is absorbed and processed.

This finding has practical implications for managing treatment comfort. Clients experiencing persistent headache during tirzepatide treatment may benefit from trialling alternative injection sites alongside other management strategies.

Our side effect management content includes non-GI symptoms that can affect treatment experience. Understanding that headache frequency varies by site provides another tool for optimising treatment tolerance.